Health Surveillance and Disease Management / Noncommunicable Diseases / Diabetes

VIIIth CAMDI Workshop: Diabetes Surveillance and Control in Central America

(Panama City, 28–29 November 2006)

CAMDI

Agenda
(3 pp, 78 Kb)

Presentations
(PowerPoint or PDF, up to 5422 Kb, titles translated for user orientation)

General
- CAMDI Progress Report
(in Spanish)
- Proposal to Improve Diabetes Care in Central America (in Spanish)
- CAMDI-QUALIDIAB: Quality of Diabetes Care in Central America: Preliminary Analysis
- CDC: Survey Weights: An Example from Honduras
- Overview of Central American STEPS (in Spanish)
- From Survey to Surveillance

From the Countries
- Belize Diabetes, Hypertension & Risk-Factors Survey
- Costa Rica: CAMDI Costa Rica (in Spanish)
- Guatemala: I   II   III (in Spanish)
- Honduras: Prevalence of Diabetes Mellitus, Arterial Hypertension, and Associated Factors: Tegucigalpa, Honduras, 2003–2004 (in Spanish)
- Mexico-USA (border):Diabetes Prevention & Control Project on the Mexican-US Border (in Spanish)
- Mexico (Veracruz): VIDA Proyect (in Spanish)
- Nicaragua: Multinational Survey on Diabetes, Hypertension, and Their Risk Factors: Managua, Nicaragua 2003 (in Spanish)

PAHO Links
About DOTA   |   VIDA Project  |
Pan American STEPS   |   PAHO Diabetes Page

General Objectives

  • Evaluate progress and results of activities related to the multinational survey on diabetes, hypertension, and risk factors for noncommunicable diseases (CAMDI-1).
  • Discuss the details of the multinational analysis and publication of the results.
  • Review plans for the intervention (CAMDI-2).
  • Begin planning the extension of the surveillance project (CAMDI-3).

Specific Objectives

  • Present activities developed and in progress in each country and preliminary results.
  • Continue with the elaboration of the data analysis.
  • Continue the development of articles and monographs using the survey results.
  • Discuss proposals and coordinate strategies for implementing the intervention to improve quality of care.
  • Develop the plan to expand risk-factor surveillance (CAMDI-3).

Coordinator: Dr. Alberto Barceló, PAHO Regional Advisor on Diabetes.

Participants: National coordinators and PAHO focal points from each country, Belize, Costa Rica, El Salvador, Honduras, Guatemala, Nicaragua and Panamá.